6-52984479-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001512.4(GSTA4):āc.399T>Gā(p.Phe133Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,612,300 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001512.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GSTA4 | NM_001512.4 | c.399T>G | p.Phe133Leu | missense_variant | 5/7 | ENST00000370963.9 | NP_001503.1 | |
GSTA4 | XM_005249035.5 | c.399T>G | p.Phe133Leu | missense_variant | 5/7 | XP_005249092.1 | ||
GSTA4 | XM_011514534.4 | c.288T>G | p.Phe96Leu | missense_variant | 4/6 | XP_011512836.1 | ||
GSTA4 | XM_011514535.4 | c.288T>G | p.Phe96Leu | missense_variant | 4/6 | XP_011512837.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GSTA4 | ENST00000370963.9 | c.399T>G | p.Phe133Leu | missense_variant | 5/7 | 1 | NM_001512.4 | ENSP00000360002.4 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249638Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134922
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460106Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726290
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 01, 2024 | The c.399T>G (p.F133L) alteration is located in exon 5 (coding exon 4) of the GSTA4 gene. This alteration results from a T to G substitution at nucleotide position 399, causing the phenylalanine (F) at amino acid position 133 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at